CTNJ op-ed: It’s a miracle — Under new agreement, Medicare will negotiate drug prices

Democrats in Washington have negotiated a deal to allow Medicare to negotiate prices with drug companies. Americans pay 2.56 times higher drug prices than residents of other developed countries. It has always been embarrassing that federal law prohibits Medicare drug price negotiation and the FDA can’t consider costs in drug approvals. The US is the only developed country that doesn’t have a government system to set reasonable prescription prices. Politically, this is a seismic shift. A rare ray of sunshine in healthcare policymaking. Read more